Is a complete PROF research report available?

No complete published report is available for Profound Medical Corp. (PROF) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Profound Medical Corp. (PROF)

NASDAQ: PROF · USD

$7.25

+0.01 (+0.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PROF analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	266.1M
Revenue (ttm)	18.8M
Net income (ttm)	-38.9M
EPS (ttm)	-$1.22
Shares out	36.3M
Volume	30,906
Beta	0.53
Price target	$11.1	+53.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 18.8M
Net income (ttm): -38.9M
EPS (ttm): -$1.22
Market cap: 266.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PROF indicators

Market & fundamental data

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001628808
Company name	Profound Medical Corp.
Country	Canada
Country code	US
Cusip	74319B502
Employees	162
Employees Change	20%
Employees Change Percent	14.08
Enterprise value	$223.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	41
Industry PE Fwd	19.92
Isin	CA74319B5027
Last refreshed	2026-07-31
Market cap	$266.1M
Market cap category	Micro-Cap
Price	$7.25
Price currency	USD
Rev Per Employee	116,135.8x
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	3841
Symbol	PROF
Website	https://www.profoundmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-14.62%
EV Sales Forward	7.81x
EV/Sales	11.87x
FCF yield	-14.54%
P/B ratio	4.48x
P/S ratio	14.14x
PS Forward	9.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-202.56%
EBITDA Margin	-199.91%
Gross margin	71.07%
Gross Profit	$13.4M
Gross Profit Growth	66.65%
Gross Profit Growth Q	106.8%
Gross Profit Growth3 Y	52.37%
Gross Profit Growth5 Y	32.42%
Net Income	$-38.9M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-205.5%
Profit Margin	-206.76%
Profit Per Employee	$-240,117
ROA	-35.46
Roa5y	-29.68
ROCE	-60.64
ROE	-70.59
Roe5y	-54.72
ROIC	-38.87

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.07%
Cagr1y	32.81%
Cagr3y	-15.27%
Cagr5y	-13.4%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	58.61x
Revenue Growth Q	103.63x
Revenue Growth Quarters	3x
Revenue Growth Years	3x
Revenue Growth3 Y	37.88x
Revenue Growth5 Y	22.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.28
Assets	$73.5M
Cash	$50.3M
Current Assets	$69.5M
Current Liabilities	$10.6M
Debt	$7.5M
Debt Equity	$0.13
Equity	$59.4M
Liabilities	$14M
Long Term Assets	$3.9M
Long Term Liabilities	$3.4M
Net Cash	$42.8M
Net Cash By Market Cap	$16.1
Net Cash Growth	3.09%
Net Debt Equity	$-0.72
Tangible Book Value	$59.3M
Tangible Book Value Per Share	$1.63
WACC	6.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.56
Inventory Turnover	0.69
Net Working Capital	$13.2M
Quick ratio	5.63
Working Capital	$58.9M
Working Capital Turnover	$0.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-21.35%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-26.77%
1Y total return	32.78%
200-day SMA	6.76
3Y total return	-39.18%
50-day SMA	6.86
50-day SMA vs 200-day SMA	50over200
5Y total return	-51.28%
All Time High	28.97
All Time High Change	-74.97%
All Time High Date	2021-02-08
All Time Low	0.03
All Time Low Change	24,066.67%
All Time Low Date	2017-07-19
ATR	0.39
Beta	0.53
Ch YTD	-7.88
High	7.36
High52	8.95
High52 Date	2026-01-13
High52ch	-18.99%
Low	7.14
Low52	3.76
Low52 Date	2025-09-10
Low52ch	92.82%
Ma50ch	5.72%
Price vs 200-day SMA	7.33%
RSI	57.5
RSI Monthly	50.47
RSI Weekly	56.23
Sharpe ratio	0.71x
Sortino ratio	1.09
Total Return	-21.35%
Tr YTD	-7.88
Tr1m	10.02%
Tr1w	5.84%
Tr3m	10.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	0
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.24
Earnings Revenue Estimate	6,340,400x
Earnings Revenue Estimate Growth	186.77x
Operating Income	$-38.1M
Operating margin	-202.6
Price target	$11.14
Price Target Change	$53.66

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34,733,113%
Float Percent	95.58%
Shares Insiders	4.42%
Shares Institutions	50.74%
Shares Out	36,337,637
Shares Qo Q	18.13%
Shares Yo Y	21.35%
Short Float	5.33%
Short Ratio	23.28
Short Shares	5.1

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-44.2M
Adjusted OCF	-44,056,000
Average Volume	121,182.75x
Bv Per Share	1.64
CAPEX	$-176,000
Ch10y	-26.77
Ch1m	10.02
Ch1w	5.84
Ch1y	32.78
Ch3m	10.69
Ch3y	-39.18
Ch5y	-51.28
Ch6m	-3.07
Change	0.14%
Change From Open	-0.14
Close	7.24
Days Gap	0.28
Depreciation Amortization	497,000
Dollar Volume	224,068.5
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$-38.1M
EBITDA	$-37.6M
EPS	$-1.22
F Score	3
FCF	$-38.7M
FCF EV Yield	-17.32x
FCF Per Share	$-1.06
Financing CF	41,428,000
Fiscal Year End	December
Income Tax	$236,000
Investing CF	-242,000
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2019-10-16
Last Split Type	Reverse
Last10k Filing Date	2026-03-05
Ma150	6.88
Ma150ch	5.38%
Ma20	7.11
Ma20ch	1.91%
Net CF	3,862,000
Next Earnings Date	2026-08-06
Open	7.26
Optionable	Yes
Position In Range	50
Ppne	3,579,000
Price Date	2026-07-30
Ptbv Ratio	4.49
Relative Volume	0.26x
Revenue	18,814,000x
SBC By Revenue	29.49x
Share Based Comp	5,549,000
Tax By Revenue	1.25x
Tr6m	-3.07%
Volume	30,906
Z Score	2

Profound Medical Corp. (PROF)

Coverage state: Market snapshot only — no published research

Generate the first PROF analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · PROF

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PROF indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PROF

Frequently asked questions